BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 19638089)

  • 21. Comparison of esophageal acid exposure distribution along the esophagus among the different gastroesophageal reflux disease (GERD) groups.
    Dickman R; Bautista JM; Wong WM; Bhatt R; Beeler JN; Malagon I; Risner-Adler S; Lam KF; Fass R
    Am J Gastroenterol; 2006 Nov; 101(11):2463-9. PubMed ID: 17090277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnostic values of GerdQ, 24-h ambulatory oesophageal pH and impedance-pH monitoring in Barrett's esophagus, reflux esophagitis and non-erosive reflux disease].
    Wang K; Duan LP; Ge Y; Xu ZJ; Xia ZW
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(18):1228-32. PubMed ID: 21756791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dilated intercellular spaces in gastroesophageal reflux disease patients and the changes of intercellular spaces after omeprazole treatment.
    Xue Y; Zhou LY; Lin SR
    Chin Med J (Engl); 2008 Jul; 121(14):1297-301. PubMed ID: 18713551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stratification and symptom characteristics of non-erosive reflux disease based on acid and duodenogastroesophageal reflux.
    Xiong LS; Chen MH; Lin JK; Hu PJ
    J Gastroenterol Hepatol; 2008 Feb; 23(2):290-5. PubMed ID: 17924953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathogenesis of proton-pump inhibitor-refractory non-erosive reflux disease according to multichannel intraluminal impedance-pH monitoring.
    Kohata Y; Fujiwara Y; Machida H; Okazaki H; Yamagami H; Tanigawa T; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():58-62. PubMed ID: 22486873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relevance of ineffective esophageal motility and hyperactive acid sensitization in patients with gastroesophageal reflux.
    Hong SJ; Ko BM; Jung IS; Ryu CB; Moon JH; Cho JY; Kim JO; Lee JS; Lee MS; Shim CS; Kim BS
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1662-5. PubMed ID: 17559356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of patients of chronic laryngitis with and without troublesome reflux symptoms.
    Wang AJ; Liang MJ; Jiang AY; Lin JK; Xiao YL; Peng S; Chen J; Wen WP; Chen MH
    J Gastroenterol Hepatol; 2012 Mar; 27(3):579-85. PubMed ID: 21793907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined multichannel intraluminal impedance and pH esophageal testing compared to pH alone for diagnosing both acid and weakly acidic gastroesophageal reflux.
    Hila A; Agrawal A; Castell DO
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):172-7. PubMed ID: 17296528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional oesophageal sensitivity to acid and weakly acidic reflux in patients with non-erosive reflux disease.
    Emerenziani S; Ribolsi M; Sifrim D; Blondeau K; Cicala M
    Neurogastroenterol Motil; 2009 Mar; 21(3):253-8. PubMed ID: 19019016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients.
    Emerenziani S; Ribolsi M; Guarino MP; Balestrieri P; Altomare A; Rescio MP; Cicala M
    Neurogastroenterol Motil; 2014 Jan; 26(1):108-14. PubMed ID: 24118616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reflux characteristics of 113 GERD patients with abnormal 24-h multichannel intraluminal impedance-pH tests.
    Nian YY; Feng C; Jing FC; Wang XQ; Zhang J
    J Zhejiang Univ Sci B; 2015 Sep; 16(9):805-10. PubMed ID: 26365123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-erosive and erosive gastroesophageal reflux diseases: No difference with regard to reflux pattern and motility abnormalities.
    Martínek J; Benes M; Hucl T; Drastich P; Stirand P; Spicák J
    Scand J Gastroenterol; 2008; 43(7):794-800. PubMed ID: 18584517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histomorphological differentiation of non-erosive reflux disease and functional heartburn in patients with PPI-refractory heartburn.
    Kandulski A; Jechorek D; Caro C; Weigt J; Wex T; Mönkemüller K; Malfertheiner P
    Aliment Pharmacol Ther; 2013 Sep; 38(6):643-51. PubMed ID: 23895770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oesophageal motility and bolus transit abnormalities increase in parallel with the severity of gastro-oesophageal reflux disease.
    Savarino E; Gemignani L; Pohl D; Zentilin P; Dulbecco P; Assandri L; Marabotto E; Bonfanti D; Inferrera S; Fazio V; Malesci A; Tutuian R; Savarino V
    Aliment Pharmacol Ther; 2011 Aug; 34(4):476-86. PubMed ID: 21671968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of combined 24-h multichannel intraluminal impedance-pH monitoring in the evaluation of children with gastrointestinal symptoms suggesting gastro-esophageal reflux disease.
    Hojsak I; Ivković L; Trbojević T; Pavić I; Jadrešin O; Mišak Z; Kolaček S
    Neurogastroenterol Motil; 2016 Oct; 28(10):1488-93. PubMed ID: 27137138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characteristics of symptomatic reflux episodes in patients with non-erosive reflux disease who have a positive symptom index on proton pump inhibitor therapy.
    Iwakiri K; Sano H; Tanaka Y; Kawami N; Umezawa M; Futagami S; Hoshihara Y; Nomura T; Miyashita M; Sakamoto C
    Digestion; 2010; 82(3):156-61. PubMed ID: 20588027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Esophageal impedance and esophagitis in children: any correlation?
    Salvatore S; Hauser B; Devreker T; Arrigo S; Marino P; Citro C; Salvatoni A; Vandenplas Y
    J Pediatr Gastroenterol Nutr; 2009 Nov; 49(5):566-70. PubMed ID: 19820412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal change esophagitis: prospective comparison of endoscopic and histological markers between patients with non-erosive reflux disease and normal controls using magnifying endoscopy.
    Kiesslich R; Kanzler S; Vieth M; Moehler M; Neidig J; Thanka Nadar BJ; Schilling D; Burg J; Nafe B; Neurath MF; Galle PR
    Dig Dis; 2004; 22(2):221-7. PubMed ID: 15383765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of rabeprazole on heartburn symptom resolution in patients with non-erosive and erosive gastro-oesophageal reflux disease: a multicenter study from Japan.
    Miwa H; Sasaki M; Furuta T; Koike T; Habu Y; Ito M; Fujiwara Y; Wada T; Nagahara A; Hongo M; Chiba T; Kinoshita Y;
    Aliment Pharmacol Ther; 2007 Jul; 26(1):69-77. PubMed ID: 17555423
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined pH-impedance monitoring and high-resolution manometry of Japanese patients treated with proton-pump inhibitors for persistent symptoms of non-erosive reflux disease.
    Yamashita H; Ashida K; Fukuchi T; Nagatani Y; Koga H; Senda K; Eguchi T; Ubukata S; Kawaguchi S; Ueda A; Tanaka T; Ohashi R; Ito D
    J Smooth Muscle Res; 2012; 48(5-6):125-35. PubMed ID: 23538509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.